1.9500
+0.0200
+(1.04%)
At close: January 10 at 3:58:41 PM EST
Breakdown
TTM
9/30/2023
9/30/2022
9/30/2021
9/30/2020
Cash Flows from Used in Operating Activities Direct
10.5310
-234.0750
479.4760
-2,980.7430
-1,904.7830
Financing Cash Flow
-712.4590
559.0000
-421.3700
2,775.3000
2,158.1000
End Cash Position
6.5600
831.2730
506.3480
448.2420
653.6850
Issuance of Capital Stock
289.0410
128.0000
369.9300
1,045.8000
1,670.1000
Issuance of Debt
500.0000
1,500.0000
--
2,200.0000
500.0000
Repayment of Debt
--
-1,000.0000
-775.0000
-425.0000
--
Free Cash Flow
10.5310
-234.0750
479.4760
-2,980.7430
-1,904.7830
9/30/2020 - 5/7/2010
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
CYTO.V Cytophage Technologies Ltd.
0.2700
-1.82%
EPRX.TO Eupraxia Pharmaceuticals Inc.
4.3200
-0.23%
GLOW.CN Glow Lifetech Corp.
0.0600
0.00%
AGN.CN Algernon Pharmaceuticals Inc.
0.0850
0.00%
MDNA.TO Medicenna Therapeutics Corp.
1.3700
-5.52%
AVBP ArriVent BioPharma, Inc.
24.88
-7.37%
NGEN.V NervGen Pharma Corp.
3.0900
+3.69%
MIR.V MedMira Inc.
0.1300
0.00%
DSGN Design Therapeutics, Inc.
4.5200
-10.94%
TVTX Travere Therapeutics, Inc.
18.09
-4.79%